An Interesting Similarity of Bacillus Calmette-Guerin and Chimeric Antigen Receptor T Cells
Intravesical Bacillus Calmette-Guerin (BCG) is approved for non-muscle invasive bladder cancer treatment a long time ago. Chimeric antigen receptor T cells (CAR-Tcell), are T cells are genetically engineered T cells that produce an artificial T-cell receptor for use in immunotherapy. Chimeric antige...
Saved in:
Main Authors: | Seyed Saeed Tamehri Zadeh, AhmadReza Rezaeian |
---|---|
Format: | article |
Language: | EN |
Published: |
Urology Research Center
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/3a53ef52572b4e01b9c5a4e99fb990af |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
by: Hongda Zhao, et al.
Published: (2021) -
Espondilodiscitis con absceso intrarraquídeo y paraespinal causada por bacilo de Calmette-Guérin (BCG)
by: Lara-Oya,Ana, et al.
Published: (2015) -
A review on the evolution of immunotherapy in bladder carcinoma
by: Milena Gulinac, et al.
Published: (2020) -
Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
by: Zheng Liu, et al.
Published: (2021) -
Infección diseminada por BCG en la Región de Los Lagos, Chile: Reporte de cinco casos clínicos
by: STRICKLER P,ALEXIS, et al.
Published: (2009)